The only gene that showed mutations in the majority of the samples was TP53, with mutations found in primary and/or PDX tumours in 27 out of 32 models (77% of samples) (Supplementary Fig 1c, Supplementary Data 2). This evidence concerns the gene TP53 and neoplasm.